{"id":"W4408207574","doi":"10.1093/braincomms/fcaf103","title":"<i>LRRK2</i> -associated parkinsonism with and without <i>in vivo</i> evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterization","year":2025,"lang":"en","type":"article","venue":"Brain Communications","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"National Institute on Aging; Avid Radiopharmaceuticals; H. Lundbeck A/S; Servier; Voyager Therapeutics; Union Chimique Belge; Bristol-Myers Squibb; Aligning Science Across Parkinson’s; Neurocrine Biosciences; Cerevel Therapeutics; Jazz Pharmaceuticals; Takeda Pharmaceuticals U.S.A.; Denali Commission; AbbVie; Janssen Biotech; Teva Pharmaceutical Industries; Verily Life Sciences; Amathus Therapeutics; Biohaven Pharmaceuticals; Celgene; Pfizer; Biogen; Roche; Michael J. Fox Foundation for Parkinson's Research; Sanofi; Weston Family Foundation; Merck","keywords":"Parkinsonism; Biomarker; Alpha-synuclein; In vivo; LRRK2; Parkinson's disease; Neuroscience; Medicine; Chemistry; Psychology; Pathology; Biology; Disease; Biochemistry; Genetics","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001035726,0.0003371933,0.0003792728,0.0005245454,0.000526845,0.0005278987,0.000324018,0.0003881488,0.0007031163],"category_scores_gemma":[0.001823633,0.0002486823,0.0004454956,0.0003067226,0.0003106644,0.0004842526,0.0004712386,0.0004243987,0.000252783],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002816195,"about_ca_system_score_gemma":0.0001715596,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002249004,"about_ca_topic_score_gemma":0.002569225,"domain_scores_codex":[0.999523,0.000122651,0.00005425011,0.0001642908,0.00007574713,0.00006005983],"domain_scores_gemma":[0.9986631,0.0001843904,0.0006569127,0.0001482353,0.0002006338,0.0001467769],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006849813,0.00007559954,0.9952938,0.000007567127,0.00008354997,0.0002639111,0.00008058788,0.000046643,0.001968947,0.00001373092,0.0000500039,0.001430801],"study_design_scores_gemma":[0.00001582894,0.0005572549,0.9971871,0.000004513347,0.00005482872,0.001232833,0.00008445101,0.000271303,0.0004141224,0.00003318111,0.0001395012,0.000005069249],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9995216,0.00006630613,0.0001104442,0.000009565816,0.000001409091,0.000008571071,0.0001008478,0.000002783636,0.0001785248],"genre_scores_gemma":[0.9994118,0.00002231052,0.00008809403,0.00001060573,0.000003408773,0.000006999941,0.000345351,0.000001719232,0.0001097032],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002249004,"threshold_uncertainty_score":0.005477488,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06547407372849434,"score_gpt":0.3627749359706621,"score_spread":0.2973008622421677,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}